Summit Therapeutics (SMMT) Reports Q1 Loss of GBP0.09/Share

Summit Therapeutics (NASDAQ: SMMT) reported Q1 EPS of (GBP0.09), versus (GBP0.06) reported last year.

For earnings history and earnings-related data on Summit Therapeutics (SMMT) click here.

You May Also Be Interested In

• Summit Therapeutics plc (SMMT) PT Raised to $9.80 at Bernstein SocGen Group
• Bristow Group to acquire Berry Aviation for $105 million
• Sunstone Hotel Investors to sell Hyatt Regency San Francisco for $279M